Appetite reducing pill? It’s being researched — but it won’t replace the mental health benefits of exercise

Credit: Getty Images
Credit: Getty Images

Researchers from the Baylor College of Medicine, publishing their findings in the journal Nature, have found a molecule produced by the body during exercise that can reduce appetite and obesity.

The research team analysed blood samples from mice who had run on a treadmill and found a modified amino acid called Lac-Phe was produced from lactate and phenylalanine. When obese mice on a high-fat diet were then given Lac-Phe, it reduced food intake by approximately 50 per cent over 12 hours.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

If we can harness this molecule and put it in pill form, could we at some point get all the benefits of exercise from simply taking a tablet? This is an exciting idea, as it may offer a way to improve the health of people who struggle to exercise due to various conditions or illnesses.

As this study demonstrates, in our world there is a lot of focus on the physical health benefits of exercise, but not so much attention on the mental and emotional benefits an active lifestyle can offer. Exercise has an impact on our self-esteem and confidence, our cognition, our sense of purpose, our ability for connection, and our sense of achievement in reaching bespoke and personalised goals.

This is an excerpt. Read the original post here. 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
Screenshot-2026-06-04-at-12.05.08-PM
Cases of brain inflammation surge as U.S. measles pandemic approaches 2000
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile ‘thought experiment’
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
ChatGPT Image May 26, 2026, 08_21_36 AM
Limiting gender affirming interventions: Trump administration targets Texas even though it already bans youth access

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.